1. Association of pulmonary function test abnormalities and quality-of-life measures after COVID-19 infection.
- Author
-
Bradley J, Xu Q, Touloumes N, Lusciks E, Ali T, Huang EC, Chen J, Ghafghazi S, Arnold FW, Kong M, Huang J, and Cavallazzi R
- Subjects
- Humans, Male, Female, Middle Aged, Prospective Studies, Aged, Adult, Surveys and Questionnaires, SARS-CoV-2, Anxiety, COVID-19 psychology, COVID-19 physiopathology, COVID-19 epidemiology, COVID-19 complications, Quality of Life, Respiratory Function Tests
- Abstract
Background: Long-COVID is a multisystem disease that can lead to significant impairments in health-related quality of life (HRQoL). Following COVID-19 infection, abnormalities on pulmonary function tests (PFT) are common. The primary aim of this study is to evaluate for any correlation between PFT abnormalities and impairment in HRQoL scores following COVID-19 infection., Methods: This is an analysis of a prospective cohort of patients in Louisville, KY who were infected with COVID-19. Data collected included demographics, past medical history, laboratory tests, PFTs, and several HRQoL questionnaires such as the EuroQol 5 Dimension HRQoL questionnaire (EQ-5D-5 L), Generalized Anxiety Disorder 7 (GAD-7), Patient Health Questionnaire (PHQ-9), and Posttraumatic stress disorder checklist for DSM-5 (PCL-5). Descriptive statistics were performed, comparing PFTs (normal vs abnormal) and time since COVID-19 infection (3- vs 6- vs ≥ 12 months)., Results: There were no significant differences in FEV1, FVC, or the percentage of patients with abnormal PFTs over time after COVID-19 infection. Following COVID-19, patients with normal PFTs had worse impairment in mobility HRQoL scores and change in GAD-7 scores over time. There were no differences over time in any of the HRQoL scores among patients with abnormal PFTs., Conclusions: Among patients with an abnormal PFT, there was no temporal association with HRQoL scores as measured by EQ-5D-5 L, GAD-7, PHQ-9, and PCL-5. Among patients with a normal PFT, mobility impairment and anxiety may be associated with COVID-19 infection. Following COVID-19 infection, impairment in HRQoL scores is not completely explained by the presence of abnormalities on spirometry., Competing Interests: Declaration of competing interest This work was supported by Gilead Sciences COMMIT COVID-19 RFP Program [grant number IN-US-983–6063]; National Center For Advancing Translational Sciences [grant number U18TR003787]; National Institute of Environmental Health Sciences [grant number P30 (P30ES030283)]; National Heart, Lung and Blood Institute 1R01HL158779–01; National Institute of Allergy and Infectious Diseases 1R01AI172873–01. Otherwise, all authors declare no other conflicts of interest in relation to this work., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF